PubRank

Masaaki Oka

Author PubWeight™ 126.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003 3.93
2 Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002 1.64
3 A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients. Proteome Sci 2013 1.44
4 Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia 2008 1.28
5 Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 2008 1.26
6 Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal 2002 1.23
7 Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 2007 1.22
8 Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 2005 1.20
9 Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett 2003 1.15
10 Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 2004 1.15
11 Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer 2009 1.14
12 Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 2002 1.12
13 TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. Genes Chromosomes Cancer 2010 1.10
14 Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer. Cancer Lett 2002 1.10
15 Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003 1.07
16 Increased expression of MUC1 in advanced pancreatic cancer. J Gastroenterol 2003 1.06
17 Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res 2008 1.05
18 Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biol Ther 2010 1.04
19 Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes. Anticancer Res 2008 1.04
20 Integrin alpha2 mediates selective metastasis to the liver. Cancer Res 2009 1.03
21 Sentinel lymph node biopsy using computed tomography-lymphography in patients with breast cancer. Surgery 2004 1.03
22 Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma. Int J Cancer 2002 1.02
23 Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004 1.00
24 Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues. BMC Cancer 2010 0.99
25 A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med 2014 0.99
26 Impact of surgical site infection after colorectal surgery on hospital stay and medical expenditure in Japan. Surg Today 2012 0.99
27 Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006 0.98
28 Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002 0.98
29 Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 2003 0.97
30 MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer. Anticancer Res 2005 0.96
31 Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. Radiology 2003 0.96
32 Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. Int J Oncol 2005 0.96
33 Lymphatic drainage from esophagogastric tract: feasibility of endoscopic CT lymphography for direct visualization of pathways. Radiology 2005 0.96
34 Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype. BMC Res Notes 2012 0.96
35 A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study). J Transl Med 2014 0.96
36 Predicting individual outcomes in hepatocellular carcinoma. Lancet 2004 0.95
37 Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism. Cancer Sci 2009 0.95
38 Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitro. Anticancer Res 2012 0.94
39 Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002 0.92
40 A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. J Pathol 2009 0.92
41 Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 2003 0.92
42 A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer. J Immunother 2014 0.92
43 Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer. Int J Cancer 2002 0.92
44 Translational microarray systems for outcome prediction of hepatocellular carcinoma. Cancer Sci 2008 0.92
45 Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Oncogene 2002 0.92
46 Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer. Anticancer Res 2009 0.92
47 Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Res 2005 0.91
48 Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. Int J Cancer 2005 0.91
49 The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues. Jpn J Clin Oncol 2010 0.90
50 The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Surg 2009 0.90
51 Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci 2015 0.90
52 Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy. Oncol Rep 2006 0.89
53 Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. J Cancer Res Clin Oncol 2006 0.89
54 Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Int J Oncol 2008 0.89
55 High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Hepatogastroenterology 2009 0.89
56 Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs. BMC Cancer 2014 0.89
57 Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1. Oncol Rep 2008 0.89
58 Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma. Anticancer Res 2007 0.88
59 CT lymphography-navigated sentinel lymph node biopsy in patients with superficial esophageal cancer. Surgery 2006 0.88
60 Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol 2004 0.88
61 Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003 0.88
62 Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res 2010 0.87
63 Prospective ultrasonographic prediction of sentinel lymph node metastasis by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography in breast cancer patients. Breast Cancer 2011 0.87
64 Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. Clin Chim Acta 2010 0.86
65 [Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer]. Gan To Kagaku Ryoho 2010 0.86
66 Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma. Oncol Rep 2008 0.86
67 UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer Sci 2013 0.86
68 Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues. Oncol Rep 2011 0.86
69 Length of stay and cost for surgical site infection after abdominal and cardiac surgery in Japanese hospitals: multi-center surveillance. Surg Infect (Larchmt) 2012 0.86
70 Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res 2009 0.86
71 Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma. FEBS Lett 2005 0.85
72 Current antibiotic prophylaxis in pancreatoduodenectomy in Japan. J Hepatobiliary Pancreat Surg 2005 0.85
73 Improvement of early delayed gastric emptying in patients with Billroth I type of reconstruction after pylorus preserving pancreatoduodenectomy. J Hepatobiliary Pancreat Surg 2009 0.85
74 Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Electrophoresis 2009 0.85
75 Breast sentinel lymph node navigation with three-dimensional interstitial multidetector-row computed tomographic lymphography. Invest Radiol 2005 0.85
76 The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma. Int J Oncol 2010 0.85
77 Germline copy number variations associated with breast cancer susceptibility in a Japanese population. Tumour Biol 2012 0.85
78 Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma. Oncol Rep 2006 0.84
79 Molecular features linked to the growth-inhibitory effects of gemcitabine on human pancreatic cancer cells. Oncol Rep 2006 0.84
80 Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. Int J Oncol 2006 0.84
81 Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinoma. Exp Ther Med 2010 0.84
82 Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 2003 0.83
83 Possible involvement of Wnt11 in colorectal cancer progression. Mol Carcinog 2011 0.83
84 Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Sci 2007 0.83
85 Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer. Oncol Rep 2005 0.82
86 DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers. Oncol Rep 2010 0.82
87 Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues. Anticancer Res 2012 0.81
88 Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity. Anticancer Res 2011 0.81
89 Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer. Hepatogastroenterology 2010 0.81
90 FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer. Mol Diagn Ther 2014 0.81
91 Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells. Cancer Lett 2004 0.81
92 [A case of disseminated tumor from cecal cancer with survival for over 5 years after twice surgical resection and systemic chemotherapy]. Gan To Kagaku Ryoho 2004 0.81
93 Protein level of apolipoprotein E increased in human hepatocellular carcinoma. Int J Oncol 2006 0.81
94 UDP-glucuronosyltransferase (UGT) 1A1*28 polymorphism-directed phase II study of irinotecan with 5'-deoxy-5-fluorouridine (5'-DFUR) for metastatic colorectal cancer. Anticancer Res 2013 0.81
95 Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors. Mol Carcinog 2008 0.81
96 Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma. Int J Oncol 2005 0.81
97 Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile. Int J Oncol 2006 0.81
98 Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells. Int J Mol Med 2004 0.81
99 In vivo motility evaluation of the grafted gastric wall with small intestinal submucosa. Tissue Eng Part A 2010 0.80
100 Is there diversity among UGT1A1 polymorphism in Japan? World J Gastrointest Oncol 2012 0.80
101 Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial. Cancer Immunol Immunother 2015 0.80
102 Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. Oncol Rep 2012 0.80
103 Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray. Life Sci 2005 0.80
104 Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma. Clin Chim Acta 2010 0.80
105 Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinoma. Clin Cancer Res 2003 0.80
106 Downregulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 2008 0.80
107 [A case of long-term disease free survival after three surgical resections for local recurrence and lung metastases from rectal cancer]. Gan To Kagaku Ryoho 2008 0.79
108 [A case of esophageal cancer associated with colon cancer successfully treated with combination chemotherapy of FOLFOX and concurrent radiotherapy]. Gan To Kagaku Ryoho 2009 0.79
109 Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography. Breast 2013 0.79
110 Concomitant overexpression of heat-shock protein 70 and HLA class-I in hepatitis C virus-related hepatocellular carcinoma. Anticancer Res 2009 0.78
111 Relationship between cytokine gene polymorphisms and risk of postoperative pneumonia with esophageal cancer. J Gastrointest Surg 2014 0.78
112 Rapid and quantitative detection of CpG-methylation status using TaqMan PCR combined with methyl-binding-domain polypeptide. Clin Biochem 2009 0.78
113 Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma. Oncol Rep 2012 0.78
114 [Evaluation of host immunity and side effects in breast cancer patients treated with adjuvant chemotherapy (FEC therapy)]. Gan To Kagaku Ryoho 2005 0.78
115 Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression. Int J Oncol 2013 0.78
116 A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy. Oncol Rep 2008 0.78
117 Identification of four isoforms of aldolase B down-regulated in hepatocellular carcinoma tissues by means of two-dimensional Western blotting. In Vivo 2011 0.78
118 Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry. Oncol Rep 2011 0.77
119 Increased expression of heat shock protein-binding protein 1 and heat shock protein 70 in human hepatocellular carcinoma tissues. Mol Med Rep 2011 0.77
120 Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract. Onco Targets Ther 2013 0.77
121 [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer]. Gan To Kagaku Ryoho 2008 0.77
122 Sentinel lymph node detection in breast cancer patients by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography. Breast J 2009 0.77
123 Influence of mesenchymal stem cells on stomach tissue engineering using small intestinal submucosa. J Tissue Eng Regen Med 2013 0.77
124 [Adjuvant hepatic arterial infusion after resection of hepatic metastasis from colorectal cancer]. Gan To Kagaku Ryoho 2006 0.77
125 Risk factors for postoperative liver failure after hepatectomy for hepatocellular carcinoma. Hepatogastroenterology 2004 0.77
126 Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion. Surg Today 2014 0.77
127 Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res 2011 0.77
128 Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Biol Ther 2015 0.77
129 Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer. Anticancer Res 2013 0.77
130 [Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer]. Nihon Rinsho 2006 0.77
131 Analysis of centromere signal patterns in breast cancer cells with chromosomal instability using image cytometry combined with centromere fluorescence in situ hybridization. Cytometry A 2014 0.76
132 Perioperative Microbiologic Monitoring of Sputum on Postoperative Day One as a Predictor of Pneumonia After Hepatectomy. J Gastrointest Surg 2015 0.76
133 Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer). Surg Today 2010 0.76
134 [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis]. Gan To Kagaku Ryoho 2009 0.76
135 Osteopontin expression in chronic pancreatitis. Pancreas 2002 0.76
136 [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion]. Gan To Kagaku Ryoho 2003 0.76
137 ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma. Int J Oncol 2013 0.76
138 [Usefulness in predicting parameters for the selection of responders who received immunochemotherapy with PSK in patients with colorectal cancer]. Gan To Kagaku Ryoho 2005 0.76
139 Expression of tropomyosin alpha 4 chain is increased in esophageal squamous cell carcinoma as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Proteomics Clin Appl 2007 0.76
140 Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Electrophoresis 2006 0.75
141 Prediction of cancer outcome with microarrays. Lancet 2005 0.75
142 [Significance of intracellular cytokines levels in peripheral lymphocytes for evaluation of surgical stress after hepatectomy in patients with hepatocellular carcinoma]. Gan To Kagaku Ryoho 2003 0.75
143 [A case of rapid growth GIST successfully treated with resection after long-term use of imatinib]. Gan To Kagaku Ryoho 2009 0.75
144 [Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer]. Gan To Kagaku Ryoho 2002 0.75
145 Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma. Anticancer Res 2007 0.75
146 [A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy]. Gan To Kagaku Ryoho 2008 0.75
147 [Genetic diagnosis of intestinal cancer]. Nihon Rinsho 2010 0.75
148 [A case of Vp4 hepatocellular carcinoma treated with surgical resection and continuous intrahepatic artery infusion chemotherapy of low-dose cisplatin and 5-fluorouracil]. Gan To Kagaku Ryoho 2003 0.75
149 Effects of moderate hypothermia on proinflammatory cytokine production in a rat model of caerulein-induced pancreatitis. Pancreas 2003 0.75
150 [A clinical study of esophagectomy after chemo-radiation therapy for advanced esophageal carcinoma]. Gan To Kagaku Ryoho 2007 0.75
151 A simple immunomonitoring procedure for mRNA-loaded dendritic cell therapy. Tumour Biol 2008 0.75
152 [A case of hepatectomy for liver metastases of advanced colon cancer after conversion therapy]. Gan To Kagaku Ryoho 2013 0.75
153 [Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer]. Nihon Rinsho 2003 0.75
154 Comparative genomic hybridization analysis for esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2004 0.75
155 [Clinical benefit of thoracoscopic approach for liver tumors located under the diaphragm]. Gan To Kagaku Ryoho 2014 0.75
156 [A case of rectal carcinoid tumor with lymph node and liver metastasis 5 years after curative resection]. Gan To Kagaku Ryoho 2013 0.75
157 [CPT-11 (Irinotecan)]. Gan To Kagaku Ryoho 2008 0.75
158 [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion]. Gan To Kagaku Ryoho 2005 0.75
159 [A case of cytomegalovirus colitis during chemotherapy for esophageal cancer]. Gan To Kagaku Ryoho 2013 0.75
160 [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer]. Gan To Kagaku Ryoho 2008 0.75
161 [A case report of a patient with overlap syndrome systemic lupus erythematosus( SLE) and polymyositis( PM)whose condition improved following treatment for coexisting descending colon cancer]. Gan To Kagaku Ryoho 2013 0.75
162 [Immunotherapy for colorectal cancer--the present status and the prospects]. Nihon Rinsho 2011 0.75
163 [Extended lymphadenectomy for gastric regional lymph node metastasis from transverse colon cancer--a case report]. Gan To Kagaku Ryoho 2009 0.75
164 [A case of advanced cervical esophageal cancer with liver cirrhosis and diabetes mellitus showing a complete response by radiation therapy after the operation for multiple esophageal cancers]. Gan To Kagaku Ryoho 2008 0.75
165 [A case of hepatocellular carcinoma with Vp4 tumor thrombus treated by radiation therapy before hepatectomy]. Gan To Kagaku Ryoho 2013 0.75
166 [A patient with intestinal gastrointestinal stromal tumor refractory to molecular targeted but whose quality of life improved after palliative surgery]. Gan To Kagaku Ryoho 2012 0.75
167 [Relationship between Polymorphisms and the Efficacy of Cetuximab]. Gan To Kagaku Ryoho 2015 0.75
168 [Immunotherapy for unresectable pancreatic cancer]. Gan To Kagaku Ryoho 2002 0.75
169 [Importance and practice of UGT1A1 polymorphisms]. Nihon Rinsho 2011 0.75
170 Post-prandial portal hemodynamics after upper gastrointestinal tract abscission. Hepatogastroenterology 2007 0.75
171 [A case of esophageal cancer with recurrent lymph-node metastasis successfully treated with chemo-radiotherapy after mediastinoscopy-assisted transhiatal esophagectomy]. Gan To Kagaku Ryoho 2008 0.75
172 [A case of unresectable advanced gastric cancer successfully treated with chemotherapy after gastrojejunostomy]. Gan To Kagaku Ryoho 2010 0.75
173 [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion]. Gan To Kagaku Ryoho 2010 0.75
174 [Epitope peptide vaccine with oncoantigen for cancer and its biomarker]. Nihon Rinsho 2012 0.75
175 [Polymorphism in colorectal cancer]. Nihon Rinsho 2003 0.75
176 Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy. Pancreas 2017 0.75
177 [Non-functional pancreatic endocrine carcinoma with multiple liver metastases--a case report]. Gan To Kagaku Ryoho 2010 0.75
178 [A case of ascending colon cancer successfully treated for synchronous liver metastases with mFOLFOX6 after a resection of the primary tumor]. Gan To Kagaku Ryoho 2009 0.75
179 [A case of metachronous liver metastasis from gastric cancer successfully treated with hepatectomy]. Gan To Kagaku Ryoho 2014 0.75
180 [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]. Gan To Kagaku Ryoho 2013 0.75
181 [Esophageal diverticula]. Nihon Geka Gakkai Zasshi 2003 0.75
182 Optimizing high-resolution melting analysis for the detection of mutations of GPR30/GPER-1 in breast cancer. Gene 2012 0.75
183 [A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs]. Gan To Kagaku Ryoho 2011 0.75
184 [An autopsy case of sepsis following radiofrequency ablation (RFA) for metastatic liver carcinoma after bile duct reconstruction]. Gan To Kagaku Ryoho 2002 0.75